Large Practice Sales (LPS) is an industry leader in monetization and acquisitions for large dental practices. In the last 36 months, LPS has completed more than $500,000,000 of transactions with IDSOs. This includes dozens of structures, valuation metrics, and acquisition growth strategies. The company has also advised doctors on hundreds of millions of dollars of larger dental practice transactions.
LPS offers dentists of all specialties the opportunity to monetize a part of their practice, without losing ownership or controlling rights to it. They represent their clients only and are paid for the transaction only when it’s closed. By doing this, LPS is able to structure a win/win deal for both IDSOs and dentists.
LPS has partnered with more than 30 IDSOs. In the past year alone, LPS has completed over $100,000,000 of dental practice transactions for doctors under 45. In addition, LPS has helped to sell practices to PE firms, family offices, and SBICs. LPS has worked with more than twenty-four IDSOs in the United States and is now focusing on partnering with five more IDSOs.
LPS has been effective at promoting cell adhesion and migration in human dental pulp stem cells. Specifically, LPS enhanced the expression of MAP-kinase, NF-kB, and MAPK pathways. In addition, LPS stimulated the production of IL-6. This pleiotropic cytokine regulates several aspects of the inflammatory response, including differentiation of regulatory T cells and Th17 cells. It is known to play a role in a variety of inflammatory pathways, such as inflammation, oxidative stress, and immune response.
A small monomer, HEMA, has been shown to diffuse through dentin. It has the potential to inhibit the release of cytokines from macrophages. It may have a protective effect on the teeth, particularly against LPS.
In addition to its role in the healing process, LPS may also affect the innate immune system. It is found in the outer membrane of Gram-negative bacteria. Lipopolysaccharide, however Andreina Dulanto, has the potential to alter cellular viability and expression of redox homeostasis proteins.
LPS can promote regenerative responses in hDPSCs by stimulating the expression of BDNF, osteocalcin, and collagen type I. It also induces odontoblastic differentiation of these cells. By co-stimulation with LPS, BDNF secretion was significantly higher in DPSCs than in BM-MSCs. Additionally, it reversed the LPS-induced decline in cell viability.
LPS has a powerful impact on the innate immune system, as well as on the response of the oral pulp cells to bacterial infections. This could have implications for the repair and restoration of the pulp tissue complex.
In addition, LPS may influence the inflammatory response in oral pulp cells. In fact, it is believed that LPS enters the pulp during deep caries. A decrease in the thickness of dentin could reduce the amount of LPS that contacts the pulp tissue. This is because the thickness of dentin is considered to be sufficient for a pulp-pulp complex to return to homeostasis. The inflammatory process is dependent on the exposure time. In fact, in an experimentally-induced model of pulp inflammation in rats, IL-6 levels were significantly higher in irreversibly inflamed pulp tissues than in healthy pulp tissues.